logo-loader
viewOpen Orphan PLC

Open Orphan's Cathal Friel on its £12mln raise to accelerate coronavirus antiviral testing

Open Orphan PLC's (LON:ORPH) Cathal Friel speaks to Proactive London's Andrew Scott after announcing they've raised approximately £12mln to ramp up its coronavirus (COVID-19) antiviral testing.

Friel says the fundraise has brought many new leading blue-chip institutional shareholders to their share register.

Quick facts: Open Orphan PLC

Price: 14.25 GBX

AIM:ORPH
Market: AIM
Market Cap: £78.24 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Open Orphan PLC named herein, including the promotion by the Company of Open Orphan PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Morning Report: FTSE 100 surges as more countries across Europe ease...

Headlines from the Proactive UK newsroom. The FTSE 100 surged 143 points higher this morning to 5,943 as more countries across Europe started to ease their lockdown restrictions. Ryanair Holdings plc (LON:RYA) has slammed its rivals for receiving state aid as its predicted a loss of over...

1 week, 1 day ago

2 min read